Catheter-related vancomycin-resistant Enterococcus faecium bacteremia: Clinical and molecular epidemiology

Infection Control and Hospital Epidemiology

Volumn 26, Issue 7, 2005, Pages 658-661

  Raad, Issam I ^a   Hanna, Hend A ^a   Boktour, Maha ^a   Jabbour, Noel ^a   Hachem, Ray Y ^a   Darouiche, Rabih O ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYURETHAN; VANCOMYCIN;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; CANCER; CASE CONTROL STUDY; CATHETER INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROCOCCUS FAECIUM; FEMALE; FEMORAL VEIN; HUMAN; INTRAVENOUS CATHETER; MALE; PARENTERAL NUTRITION; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADULT; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; CASE-CONTROL STUDIES; CATHETERIZATION; COMORBIDITY; DNA, BACTERIAL; ENTEROCOCCUS FAECIUM; FEMALE; GASTROINTESTINAL TRACT; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TEXAS; VANCOMYCIN RESISTANCE;

EID: 23044446967     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502598     Document Type: Article

References (18)

1. Fridkin SK, Gaines RP. Antimicrobial resistance in intensive care units. Clin Chest Med 1999;20:303-316.
2. Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med 2000;342:710-721.
3. Beezhold D, Slaughter S, Hayden M, et al. Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia. Clin Infect Dis 1997;24:704-706.
4. Roghmann M, Qaiyumi S, Johnson J, Schwalbe R, Morris J Jr. Recurrent vancomycin-resistant Enterococcus faecium bacteremia in a leukemia patient who was persistently colonized with vancomycin-resistant enterococci for two years. Clin Infect Dis 1997;24:514-515.
5. Moellering RC, Linden PK, Reinhardt J, et al. The efficacy and safety of Q-D for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 1999;44:251-261.
6. Leach TS, Schaser R, Todd WM, et al. Clinical efficacy of linezolid for infections caused by vancomycin-resistant enterococci (VRE) in a compassionate use program. Clin Infect Dis 2000;31:224.
7. Murray BE, Singh KV, Heath JD, et al. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol 1990;29:2059-2063.
8. Tenover FC, Arbeit RD, Goering RV, et al. Guest commentary. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-2239.
9. Mermel LA, Farr BM, Sherertz RJ, O'Grady N, Harris JS, Craven DE. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001;32:1249-1272.
10. Sandoe JAT, Witherden IR, Au-Yeung H-KC, Kite P, Kerr KG, Wilcox MH. Enterococcal intravascular catheter-related bloodstream infection: management and outcome of 61 consecutive cases. J Antimicrob Chemother 2002;50:577-582.
11. Merrer J, DeJonghe B, Golliot F, et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 2001;286:700-707.
12. Schierholz J, Lefering R, Neugebauer E, Beuth J, Konig DP, Pulverer G. Central venous catheters and bloodstream infection. JAMA 2000;283:477-478.
13. Bijma R, Girbes AR, Kleijer DJ, Zwaveling JH. Preventing central venous catheter-related infection in a surgical intensive-care unit. Infect Control Hosp Epidemiol 1999;20:618-620.
14. Santarpia L, Pasanisi F, Alfonsi L, et al. Prevention and treatment of implanted central venous catheter (CVC)-related sepsis: a report after six years of home parenteral nutrition (HPN). Clin Nutr 2002;21:207-211.
15. Kemp L, Burge J, Choban P, Harden J, Mirtallo J, Flancbaum L. The effect of catheter type and site on infection rates in total parenteral nutrition patients. JPEN J Parenter Enteral Nutr 1994;18:71-74.
16. Bonten M, Hayden MK, Nathan C, et al. Epidemiology of colonization of patients and environment with vancomycin-resistant enterococci. Lancet 1996;348:1615-1619.
17. Hanna H, Umphrey J, Tarrand J, Mendoza M, Raad I. Management of an outbreak of vancomycin-resistant enterococci in the medical intensive care unit of a cancer center. Infect Control Hosp Epidemiol 2001;22:217-219.
18. Raad II, Hanna HA, Chaiban G, et al. The presence of the esp gene bioprosthetic colonization, and DNA restriction pattern of vancomycin-resistant Enterococcus faecium (VREF) causing catheter-related bacteremia (CRB). Presented at the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 14-17, 2003; Chicago, IL.